Selective modulation of promoter recruitment and transcriptional activity of PPARγ

Biochemical and Biophysical Research Communications

Volumn 364, Issue 3, 2007, Pages 515-521

  Sears, Dorothy D ^a   Hsiao, Albert ^a   Ofrecio, Jachelle M ^a   Chapman, Justin ^b   He, Weimin ^a   Olefsky, Jerrold M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b PFIZER INC   (United States)

Author keywords

3T3 L1 adipocytes; Chromatin immunoprecipitation; Microarray; Selective peroxisome proliferator activated receptor modulator (SPPARM); Thiazolidinedione (TZD); Transcription

Indexed keywords

GLITAZONE DERIVATIVE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RNA; ROSIGLITAZONE; TROGLITAZONE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

3T3-L1 CELLS; ANIMALS; GENE EXPRESSION REGULATION; MICE; PPAR GAMMA; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS);

EID: 35648972677     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.10.057     Document Type: Article

References (29)

1. Olefsky J.M., and Saltiel A.R. PPARγ and the treatment of insulin resistance. Trends Endocrinol. Metabol. 11 (2000) 362-368
2. Berger J.P., Petro A.E., Macnaul K.L., et al. Distinct properties and advantages of a novel PPARγ selective modulator. Mol. Endocrinol. 17 (2003) 662-676
3. Wilson-Fritch L., Burkart A., Bell G., et al. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 23 (2003) 1085-1094
4. Way J.M., Harrington W.W., Brown K.K., et al. Comprehensive messenger ribonucleic acid profiling reveals that PPARγ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology 142 (2001) 1269-1277
5. Huang J., Hsia S.H., Imamura T., et al. Annexin II is a thiazolidinedione-responsive gene involved in insulin-induced glucose transporter isoform 4 translocation in 3T3-L1 adipocytes. Endocrinology 145 (2004) 1579-1586
6. Ribon V., Johnson J.H., Camp H.S., et al. Thiazolidinediones and insulin resistance: PPARγ activation stimulates expression of the CAP gene. Proc. Natl. Acad. Sci. USA 95 (1998) 14751-14756
7. Imamura T., Vollenweider P., Egawa K., et al. G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol. Cell. Biol. 19 (1999) 6765-6774
8. Beale E.G., Forest C., and Hammer R.E. Regulation of cytosolic phosphoenolpyruvate carboxykinase gene expression in adipocytes. Biochimie 85 (2003) 1207-1211
9. Guan H.P., Li Y., Jensen M.V., et al. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med. 8 (2002) 1122-1128
10. Hauser S., Adelmant G., Sarraf P., et al. Degradation of the PPARγ is linked to ligand-dependent activation. J. Biol. Chem. 275 (2000) 18527-18533
11. Camp H.S., Whitton A.L., and Tafuri S.R. PPARγ activators down-regulate the expression of PPARγ in 3T3-L1 adipocytes. FEBS Lett. 447 (1999) 186-190
12. Young P.W., Buckle D.R., Cantello B.C.C., et al. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for PPARγ. J. Pharmacol. Exp. Ther. 284 (1998) 751-759
13. Camp H.S., Li O., Wise S.C., et al. Differential activation of PPARγ by troglitazone and rosiglitazone. Diabetes 49 (2000) 539-547
14. Olefsky J.M. Treatment of insulin resistance with PPARγ agonists. J. Clin. Invest. 106 (2000) 467-472
15. Wu Y., Chin W.W., Wang Y., et al. Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the PPARγ. J. Biol. Chem. 278 (2003) 8637-8644
16. Wang Y., Porter W.W., Suh N., et al. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the PPARγ. Mol. Endocrinol. 14 (2000) 1550-1556
17. Rocchi S., Picard F., Vamecq J., et al. A unique PPARγ with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell. 8 (2001) 737-747
18. Worrall D.S., and Olefsky J.M. The effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes. Mol. Endocrinol. 16 (2002) 378-389
19. Hsiao A., Ideker T., Olefsky J.M., et al. VAMPIRE microarray suite: a web-based platform for the interpretation of gene expression data. Nucleic Acids Res. 33 (2005) W627-W632
20. Hsiao A., Worrall D.S., Olefsky J.M., et al. Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes. Bioinformatics 20 (2004) 3108-3127
21. Baek S.H., Ohgi K.A., Rose D.W., et al. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110 (2002) 55-67
22. Kaeser M.D., and Iggo R.D. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. USA 99 (2002) 95-100
23. Berger J., Tanen M., Elbrecht A., et al. PPARγ ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J. Biol. Chem. 276 (2001) 12629-12635
24. Sakamoto J., Kimura H., Moriyama S., et al. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone. Biochem. Biophys. Res. Commun. 278 (2000) 704-711
25. Wurch T., Junquero D., Delhon A., et al. Pharmacological analysis of wild-type alpha, gamma, and delta subtypes of the human peroxisome proliferator-activated receptor. Naunyn. Schmiedebergs Arch. Pharmacol. 365 (2002) 133-140
26. Perissi V., and Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell. Biol. 6 (2005) 542
27. Frohnert B.I., Hui T.Y., and Bernlohr D.A. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J. Biol. Chem. 274 (1999) 3970-3977
28. Kishida K., Shimomura I., Nishizawa H., et al. Enhancement of the aquaporin adipose gene expression by a PPARγ. J. Biol. Chem. 276 (2001) 48572-48579
29. Feige J.N., Gelman L., Tudor C., et al. Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J. Biol. Chem. 280 (2005) 17880-17890